Traduction de «merger » (Néerlandais → Français) :

This merger, which is governed under the Swiss Merger Act, proposes a fixed exchange ratio of 2.80 Novartis shares for each remaining Alcon share.
Soumise à la loi fédérale suisse sur les fusions, cette fusion propose une parité fixe de 2,80 actions Novartis pour chacune des actions Alcon restantes.

This merger, which will be implemented under the Swiss Merger Act, is in the interest of all stakeholders and will provide the needed clarity on Alcon’s future.
Cette fusion, qui sera réalisée conformément à la loi fédérale sur la fusion, est dans l'intérêt de toutes les parties prenantes en clarifiant l’avenir d’Alcon.

The merger would also require two-thirds approval by the shareholders of Novartis and Alcon voting at their respective meetings.
Elle nécessiterait aussi d’être approuvée par les deux tiers des actionnaires de Novartis et d’Alcon qui seront appelés à voter lors de leurs assemblées respectives.

The merger requires approval by the Boards of Directors of Novartis and Alcon.
Cette fusion nécessite l’approbation des Conseils d’administration de Novartis et d’Alcon.

Novartis believes this merger, which is governed under the Swiss Merger Act, is in the interest of all stakeholders and will provide the needed clarity on Alcon’s future.
Novartis est convaincu que cette fusion, qui sera réalisée conformément à la loi fédérale suisse sur la fusion, est dans l’intérêt de toutes les parties prenantes en apportant la clarté nécessaire à l’avenir d’Alcon.

Under Swiss law, Novartis has the right to vote its Alcon stake in favor of the proposed merger.
En vertu de la loi suisse, Novartis a le droit d’utiliser les droits de vote que lui confère sa participation dans Alcon en faveur de la fusion proposée.

1974 on the opening, transfer and merger of retail pharmacies Royal decree of 9 July 1984 on the provision of information and advertising relating to medicines Royal decree of 11 January 1993 determining the conditions under which medicines for human use may be supplied in sample form Royal decree of 7 April 1995 on the provision of information and advertising relating to medicines for human use Royal decree of 15 July 1997 on active implantable medical devices, transposing Directive 90/385 EEC (AIMD) Royal decree of 19 December 1997 on the control and analysis of the raw materials used by dispensing chemists Royal decree of 18 March 1999 on medical devices, transposing Directive 93/42/EEC of 14 June 1993 (MDD) Royal decree of 11 July 2003 determining the conditions under which medicines for veterinary use may be supplied in sample form Law of 16 December 2004 modifying the regulations on combating abuses in the promotion of medicines Royal decree of 10 June 2006 establishing the report point referred to in Article 10, § 5, of the law of 25 March 1964 on medicines Royal decree of 23 November 2006 implementing Article 10, § 3, of the law of 25 March 1964 on medicines Royal decree of 25 February 2007 recognising the institutions referred to in Article 10 § 3 of the law of 25 March 1964 on medicines
1974 on the opening, transfer and merger of retail pharmacies Royal decree of 9 July 1984 on the provision of information and advertising relating to medicines Royal decree of 11 January 1993 determining the conditions under which medicines for human use may be supplied in sample form Royal decree of 7 April 1995 on the provision of information and advertising relating to medicines for human use Royal decree of 15 July 1997 on active implantable medical devices, transposing Directive 90/385 EEC (AIMD) Royal decree of 19 December 1997 on the control and analysis of the raw materials used by dispensing chemists Royal decree of 18 March 1999 on medical devices, transposing Directive 93/42/EEC of 14 June 1993 (MDD) Royal decree of 11 July 2003 determining the conditions under which medicines for veterinary use may be supplied in sample form Law of 16 December 2004 modifying the regulations on combating abuses in the promotion of medicines Royal decree of 10 June 2006 establishing the report point referred to in Article 10, § 5, of the law of 25 March 1964 on medicines Royal decree of 23 November 2006 implementing Article 10, § 3, of the law of 25 March 1964 on medicines Royal decree of 25 February 2007 recognising the institutions referred to in Article 10 § 3 of the law of 25 March 1964 on medicines

On January 4, Novartis also announced its proposal, upon completion of the Nestlé transaction, to enter into an all-share direct merger with Alcon for the remaining 23% minority stake.
Le 4 janvier, Novartis a aussi annoncé sa proposition d’entamer une fusion-absorption de la part minoritaire restante de 23% dans Alcon, après l’achèvement de la transaction avec Nestlé.

On 1 January 2007, the FAMHP took over 325 Dutch-language applications that had not yet been finalised on the basis of the establishment regulations (royal decree of 25 September 1974 on the opening, transfer and merger of retail pharmacies).
On 1 January 2007, the FAMHP took over 325 Dutch-language applications that had not yet been finalised on the basis of the establishment regulations (royal decree of 25 September 1974 on the opening, transfer and merger of retail pharmacies).